PMV Pharmaceuticals Inc.

NASDAQ: PMVP · Real-Time Price · USD
1.50
-0.05 (-3.23%)
At close: Aug 15, 2025, 3:59 PM
1.49
-1.00%
After-hours: Aug 15, 2025, 05:54 PM EDT

PMV Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-80.87M -60.88M -58.71M -51.47M -48.88M -65.1M -68.96M -72.55M -74.14M -74.01M -73.32M -72.33M -69.11M -64.68M -57.85M -49.94M -43.7M -38.79M
Depreciation & Amortization
479K 819K 1.14M 1.46M 1.45M 1.45M 1.26M 973K 689K 402K 315K 317K 323K 312K 307K 291K 286K 303K
Stock-Based Compensation
6.67M 7.77M 8.87M 10.57M 11.67M 12.05M 12.38M 12.46M 11.59M 10.95M 10.2M 8.91M 8.26M 6.89M 5.34M 4.16M 3.03M 2.26M
Other Working Capital
5.07M -656K -1.9M 1.93M -3.71M 2.07M 3.38M 5.22M 1.07M 3.54M -179K 716K 5.26M 3.55M 3.93M -1.66M -960K -1.32M
Other Non-Cash Items
-476K -3.33M 1.51M -6.83M -2.5M -948K -5.76M -1.44M -1.5M -1.32M -385K 390K 859K 1.26M 1.29M 958K 746K 305K
Deferred Income Tax
n/a n/a n/a 2.8M 957K n/a n/a -2.8M -957K n/a n/a 91K 218K 218K 218K 127K 5K 65K
Change in Working Capital
4.13M 2.08M 1.45M 2.31M -2.68M 1.44M 5.43M 4.46M 4.33M 3.21M -568K 2.16M 3.35M 4.33M 4.12M -447K -223K -1.66M
Operating Cash Flow
-70.07M -53.36M -51.28M -46.71M -45.53M -56.83M -55.66M -58.9M -60M -60.77M -63.76M -60.46M -56.1M -51.66M -46.57M -44.85M -39.85M -37.51M
Capital Expenditures
-72K -65K -655K -796K -839K -1.4M -962K -2.4M -4.41M -7.34M -7.98M -6.61M -5.06M -2.02M -1.35M -1.14M -683K -217K
Cash Acquisitions
n/a n/a n/a -47.19K -13.6K 49.8K n/a 22.33K -42.83K -94.45K -44.65K 2.72M 2.75M 2.74M 2.74M n/a n/a n/a
Purchase of Investments
-123.6M -133.52M -148.29M -144.16M -162.36M -227.53M -220.54M -221.83M -209.53M -159M -229.2M -216.19M -220.84M -210.77M -256.85M -249.78M -199.74M -154.08M
Sales Maturities Of Investments
187.96M 189.24M 202.04M 187.95M 155.46M 154.9M 170.96M 199.5M 252.35M 253.44M 235.81M 205.77M 178.66M 170.29M 114.61M 77.14M 35.36M 26.11M
Other Investing Acitivies
281K 2.58M 29.34M 29.16M 29.1M 26.71M n/a -22.33K 42.83K 94.45K -37.98M -40.75M -40.97M -51.05M -152.8M -127.47M -119.2M -82.8M
Investing Cash Flow
64.56M 55.9M 53.35M 43.02M -7.74M -74.02M -50.55M -24.73M 38.42M 87.1M -1.37M -17.03M -47.24M -42.51M -143.58M -151.2M -142.47M -105.6M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
31K 182K 172K 288K 480K 2.47M 2.48M 2.74M 2.7M 842K 958K 705K 1.01M 1.99M 2.02M 368K 294.51M 293.13M
Financial Cash Flow
285K 323K 313K 429K 33.58M 35.56M 35.58M 35.84M 2.7M 842K 958K 705K 1.01M 1.99M 2.02M 368K 294.51M 293.13M
Net Cash Flow
-5.22M 2.87M 2.35M -3.25M -19.68M -95.29M -70.59M -47.79M -18.88M 27.17M -64.17M -76.79M -102.33M -92.19M -188.13M -195.69M 112.19M 150.03M
Free Cash Flow
-70.14M -53.43M -51.94M -47.5M -46.37M -58.23M -56.62M -61.3M -64.41M -68.12M -71.74M -67.07M -61.16M -53.69M -47.92M -46M -40.53M -37.72M